Health
Andrew and Nicola Forrest’s Mindaroo an investor in COVID nasal spray developed by Hunter researcher Nathan Bartlett – Armidale Express
A nasal spray that could stop COVID-19 and the common cold in its tracks is one step closer to market after $32 million funding…
Hope: Hunter researcher Nathan Bartlett led studies into a nasal spray treatment that could prevent COVID-19. The project has secured $32 million to start human clinical trials. Picture: Jonathan Carroll
Continue Reading
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business21 hours agoThese ASX 200 shares could rise 50% to 60%
-
General21 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General23 hours agoPort’s lease a ‘mistake’ as major parties flag takeover